According to Actinium Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -NZ$75.5 M. In 2023 the company made an earning of -NZ$83.93 M a decrease over its 2022 earnings that were of -NZ$55.13 M.The earnings displayed on this page is the company's Pretax Income.